Dale Fisher

Last updated
Dale Fisher
Dale Fisher 2023.jpg
Born
Dale Andrew Fisher

1960 (age 6364)
Melbourne, Australia
Education
Medical career
Field
Institutions
Website www.nuh.com.sg/patients-visitors/Pages/find-a-doctor-details.aspx?docid=Dale_Fisher

Dale Andrew Fisher FRACP (born 1960) is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. [1] He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore (2004 -), and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore (2013 -). [2] In 2020, he became group chief of Medicine for National University Health Systems.

Contents


Early life and education

In 1976, he attended United World College of South East Asia in Singapore [3] under an Australian government scholarship.

Career and research

Fisher was also the infectious disease physician who attended to comedian Jerry Lewis, when the late comedian was admitted to hospital for meningitis while on tour in Darwin. [4] Lewis, when interviewed by Larry King, said "God must have put him in 'the bush' (aka Darwin) because Dr Fisher was the world's best infectious disease physician." [5]

Bali Bombings - 2002

Following the bombing, Fisher wrote an article titled "The Bali bombings of 12 October 2002: lessons in disaster management for physicians", which was published in 2003. Fisher's team highlighted that hospital-based physicians should see themselves as a sizeable and flexible group with the ability to contribute in a variety of ways during a disaster. [6]

SARS - 2003

Reunion of Singapore medical staff (from left: Fisher, Paul Tambyah) on the 10th Anniversary of the SARS outbreak in Singapore SARS Reunion.jpg
Reunion of Singapore medical staff (from left: Fisher, Paul Tambyah) on the 10th Anniversary of the SARS outbreak in Singapore

During the SARS pandemic in 2003 in Singapore, Fisher with colleagues published several articles related to "Lessons from Singapore". In these articles, it was described that SARS had demonstrated a remarkable efficiency in transmission within hospitals. In fact, 76% of SARS cases in Singapore were acquired in hospitals. They also looked at the circumstances that caused transmission within hospitals, despite the use of personal protective equipment (PPE). [7]

The outbreak in hospitals resulted in dramatic changes in triage and infection-control policies. [8]

In a separate article titled "Atypical presentations of SARS" published in The Lancet , Fisher and colleagues examined the difficulties of managing SARS cases without a diagnostic test. [9] This letter described how the World Health Organization's criteria for probable or suspected SARS case had been misinterpreted. They were intended for epidemiological purposes but instead were used for triage for which they were not adequately sensitive.

Methicillin resistant Staphylococcus aureus - 2008

Methicillin-Resistant Staphylococcus aureus (MRSA) Ingestion by a Neutrophil (8423852305).jpg

In the article titled "Methicillin-resistant Staphylococcus aureus Control in Singapore– Moving Forward", he described how MRSA infection in hospitals could be prevented and should not be considered as an accepted tolerable by-product of healthcare. Failure to implement long-term sustainable infection control initiatives is not an option. It was also concluded that the control of MRSA in Singapore could be achieved, but it required implementation of many varied control measures across health services, and possibly would take a decade to do so. [10]

Among many other papers on MRSA, in 2013 he published "Sustained MRSA control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore". It highlighted falls in bacteraemia, all clinical specimens as well as acquisition rates as a result of the previously described interventions. [11]

For their efforts in reducing the rate of MRSA superbug infection from 1 in 10 patients to 1 in 40, Fisher and his colleagues were awarded the National Clinical Excellence Team Award in 2013 by the Ministry of Health, Singapore. [12]

COVID-19

During the ongoing COVID-19 pandemic, which began in Wuhan, China, Fisher was part of the WHO delegation that visited China to investigate technical aspects of transmission, severity and interventions preventing spread of the emerging virus. The subsequent report outlined how the world could respond to the outbreak, but warned that the world was not prepared "in capacity or mindset". [13]

He is also involved in many pilot projects that spearhead on research and response. In his article "Q&A: The novel coronavirus outbreak causing COVID-19", Fisher shared his concerns about the emerging virus. For instance, the world's population is completely vulnerable to the novel virus as it is newly emerged in humans, and the current aim of the response muts be to flatten the epidemic curve, by interrupting chains of transmission wherever possible. It was also mentioned that while there were deaths linked to the virus, the greatest concern is the overwhelming of a health system in the wake of excessive transmission. [14]

Fisher is now well known to the media for commentary regarding COVID-19 offered through television, radio, print and social media in dozens of countries of every continent and outlets including CNN, [15] CNBC, [16] BBC, [17] ABC Australia, et cetera. In addition he undertook many webinars and other virtual speaking engagements. His philosophy was that COVID-19 can and must be contained. [18] The key outbreak pillars of case management epidemiology, logistics and risk communication/community engagement are critical at all levels. Isolation of cases that are confirmed early by testing is particularly important in this outbreak. [16]

As in some ways the public face of the response in Singapore, Fisher has featured in a comic series "The COVID Chronicles". [19]


Related Research Articles

Methicillin-resistant <i>Staphylococcus aureus</i> Bacterium responsible for difficult-to-treat infections in humans

Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from other strains of Staphylococcus aureus. MRSA is responsible for several difficult-to-treat infections in humans. It caused more than 100,000 deaths worldwide attributable to antimicrobial resistance in 2019.

<span class="mw-page-title-main">SARS</span> Disease caused by severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.

<span class="mw-page-title-main">Contact tracing</span> Finding and identifying people in contact with someone with an infectious disease

In public health, contact tracing is the process of identifying persons who may have been exposed to an infected person ("contacts") and subsequent collection of further data to assess transmission. By tracing the contacts of infected individuals, testing them for infection, and isolating or treating the infected, this public health tool aims to reduce infections in the population. In addition to infection control, contact tracing serves as a means to identify high-risk and medically vulnerable populations who might be exposed to infection and facilitate appropriate medical care. In doing so, public health officials utilize contact tracing to conduct disease surveillance and prevent outbreaks. In cases of diseases of uncertain infectious potential, contact tracing is also sometimes performed to learn about disease characteristics, including infectiousness. Contact tracing is not always the most efficient method of addressing infectious disease. In areas of high disease prevalence, screening or focused testing may be more cost-effective.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

<span class="mw-page-title-main">Isolation (health care)</span> Measure taken to prevent contagious diseases from being spread

In health care facilities, isolation represents one of several measures that can be taken to implement in infection control: the prevention of communicable diseases from being transmitted from a patient to other patients, health care workers, and visitors, or from outsiders to a particular patient. Various forms of isolation exist, in some of which contact procedures are modified, and others in which the patient is kept away from all other people. In a system devised, and periodically revised, by the U.S. Centers for Disease Control and Prevention (CDC), various levels of patient isolation comprise application of one or more formally described "precaution".

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Emerging Pathogens Institute</span>

The Emerging Pathogens Institute (EPI) is an interdisciplinary research institution associated with the University of Florida. The institute focuses on fusing key disciplines to develop outreach, education, and research capabilities designed to preserve the region's health and economy, as well as to prevent or contain new and re-emerging diseases. Researchers within the institute work in more than 30 different countries around the world, with over 250 affiliated faculty members stemming from 11 University of Florida colleges, centers, and institutes. The 90,000-square-foot building includes laboratories and collaborative space for bioinformatics and mathematical modeling.

<span class="mw-page-title-main">Airborne transmission</span> Disease transmission by airborne particles

Airborne transmission or aerosol transmission is transmission of an infectious disease through small particles suspended in the air. Infectious diseases capable of airborne transmission include many of considerable importance both in human and veterinary medicine. The relevant infectious agent may be viruses, bacteria, or fungi, and they may be spread through breathing, talking, coughing, sneezing, raising of dust, spraying of liquids, flushing toilets, or any activities which generate aerosol particles or droplets.

<span class="mw-page-title-main">Superspreading event</span> Event in which 3 or more people attend and an infectious disease is spread much more than usual

A superspreading event (SSEV) is an event in which an infectious disease is spread much more than usual, while an unusually contagious organism infected with a disease is known as a superspreader. In the context of a human-borne illness, a superspreader is an individual who is more likely to infect others, compared with a typical infected person. Such superspreaders are of particular concern in epidemiology.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Samira Mubareka is a Canadian microbiologist who is a clinical scientist at the Sunnybrook Health Sciences Centre in Toronto, Ontario. Her research considers the influenza virus, viral transmission and aerobiology. During the COVID-19 pandemic Mubareka isolated the genome of Severe acute respiratory syndrome coronavirus 2 in an effort to improve detection and diagnostics. She served as a member of the Ontario COVID-19 Science Advisory Table.

Helen Y. Chu is an American immunologist who is an assistant professor of medicine at the University of Washington. Her research considers maternal immunization, with a focus on influenza and respiratory syncytial virus. During the COVID-19 pandemic, Chu was the first physician to recognise community transmission of the coronavirus disease within the United States.

<span class="mw-page-title-main">Andrea Ammon</span> German physician

Andrea Ammon is a German physician and the current director of the European Centre for Disease Prevention and Control (ECDC), a European Union (EU) agency strengthening Europe's defence against infectious disease. She advised the German government on the SARS and Influenza A virus subtype H2N2 outbreaks.

<span class="mw-page-title-main">Paul Tambyah</span> Singaporean doctor, professor and politician

Paul Anantharajah Tambyah, is a Singaporean doctor and professor of infectious diseases, a politician, and a writer. He is President of the Asia Pacific Society of Clinical Microbiology and Infection and also President of the International Society for Infectious Diseases. He is also the Chairman of the Singapore Democratic Party, a position he has held since September 2017.

<span class="mw-page-title-main">Transmission of COVID-19</span> Mechanisms that spread coronavirus disease 2019

The transmission of COVID-19 is the passing of coronavirus disease 2019 from person to person. COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

<span class="mw-page-title-main">Saskia Popescu</span> Infectious disease epidemiologist

Saskia Popescu is an infectious disease epidemiologist and global health security expert in Phoenix, Arizona. She is an Assistant Professor of epidemiology at the University of Maryland, and holds academic appointments at the University of Arizona and George Mason University’s Schar School of Policy and Government, where she lectures on biopreparedness and outbreak response. Since the start of the Coronavirus disease 2019 pandemic, Popescu has worked to prepare for and mitigate the spread of the disease within healthcare and the entertainment industry, where she led the global epidemiology and infection prevention response for Netflix. She has been recognized for her communication efforts around the pandemic, as well as her work on the front lines in infection prevention and healthcare biopreparedness. Popescu currently is a Senior Fellow at the Council on Strategic Risks, addressing converging biological risks from biological weapons nonproliferation, biosecurity, emerging infectious diseases and ecological security, biopreparedness in private industry, and global health security vulnerabilities.

<span class="mw-page-title-main">Yee-Sin Leo</span> Singaporean physician

Yee-Sin Leo is a Singaporean physician. Leo is the executive director of the National Centre for Infectious Diseases and researches emerging infectious diseases. She has been in charge of Singapore's response to several outbreaks, including Nipah, SARS and COVID-19. In 2020, she was selected as one of the BBC's top 100 Women.

In the 2020 dengue outbreak in Singapore, a record-breaking number of dengue fever cases was reported in Singapore. This was part of the wider 2019–2020 dengue fever epidemic which also affected several neighbouring countries in Southeast Asia.

An occupational infectious disease is an infectious disease that is contracted at the workplace. Biological hazards (biohazards) include infectious microorganisms such as viruses, bacteria and toxins produced by those organisms such as anthrax.

References

  1. "Find A Doctor - NUH | National University Hospital". www.nuh.com.sg. Retrieved 2020-05-14.
  2. "The National Infection Prevention and Control Guidelines For Acute Healthcare Facilities 2017" (PDF). Ministry of Health, Singapore. Retrieved 14 May 2020.
  3. "UWCSEA alumnus is infectious disease specialist at the National University of Singapore" (PDF). UWCSEA Alumni. Archived from the original (PDF) on 17 April 2020. Retrieved 13 May 2020.
  4. "Meningitis Hospitalizes Jerry Lewis". AP NEWS. Retrieved 2020-05-14.
  5. "'Bush' doctor". Northern Territory News. September 1999.
  6. Fisher, D.; Burrow, J. (2003). "The Bali bombings of 12 October, 2002: lessons in disaster management for physicians". Internal Medicine Journal. 33 (3): 125–126. doi: 10.1046/j.1445-5994.2003.00371.x . ISSN   1445-5994. PMID   12603586.
  7. Fisher, Dale A.; Chew, Madeleine H. L.; Lim, Yean-Teng; Tambyah, Paul A. (2003-06-02). "Preventing local transmission of SARS: lessons from Singapore". The Medical Journal of Australia. 178 (11): 555–558. doi:10.5694/j.1326-5377.2003.tb05358.x. PMC   7168499 . PMID   12765503.
  8. Singh, Kamaljit; Hsu, Li-Yang; Villacian, Jorge S.; Habib, Abdulrazaq; Fisher, Dale; Tambyah, Paul A. (2003). "Severe Acute Respiratory Syndrome: Lessons from Singapore". Emerging Infectious Diseases. 9 (10): 1294–8. doi:10.3201/eid0910.030388. PMC   3033073 . PMID   14609466.
  9. Fisher, Dale A.; Lim, Tow-Keang; Lim, Yean-Teng; Singh, Kamaljit S.; Tambyah, Paul A. (2003-05-17). "Atypical presentations of SARS". The Lancet. 361 (9370): 1740. doi:10.1016/S0140-6736(03)13336-3. ISSN   0140-6736. PMID   12767755. S2CID   26668557.
  10. Lynette Pereira; Dale Fisher (October 2008). "Methicillin Resistant Staphylococcus aureus Control in Singapore - Moving Forward" (PDF). ANNALS Academy of Medicine. 37: 891–896.
  11. Fisher, D.; Tambyah, P. A.; Lin, R. T. P.; Jureen, R.; Cook, A. R.; Lim, A.; Ong, B.; Balm, M.; Ng, T. M.; Hsu, L. Y. (2013-10-01). "Sustained meticillin-resistant Staphylococcus aureus control in a hyper-endemic tertiary acute care hospital with infrastructure challenges in Singapore". Journal of Hospital Infection. 85 (2): 141–148. doi:10.1016/j.jhin.2013.07.005. ISSN   0195-6701. PMC   7114850 . PMID   24011440.
  12. Khalik, Salma (25 July 2013). "NUH team saves patients from superbug". The Straits Times . Retrieved 14 May 2020.
  13. "Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)" (PDF). World Health Organization . Retrieved 14 May 2020.
  14. Fisher, Dale; Heymann, David (2020-02-28). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine. 18 (1): 57. doi: 10.1186/s12916-020-01533-w . ISSN   1741-7015. PMC   7047369 . PMID   32106852.
  15. Griffiths, James (19 April 2020). "Singapore had a model coronavirus response, then cases spiked. What happened?". CNN. Retrieved 2020-05-14.
  16. 1 2 "Coronavirus containment is not futile, it has to be contained: Infectious diseases professor in Singapore". CNBC. 2020-03-23. Retrieved 2020-05-14.
  17. Jones, Anna (2020-04-10). "Should world worry about Singapore's virus surge?". BBC News. Retrieved 2020-05-14.
  18. "Professor analyses 'countries that have successfully contained' the deadly coronavirus". Sky News Australia. 18 March 2020. Retrieved 2020-05-14.
  19. Fisher, Dale (18 March 2020). "Why Singapore's coronavirus response worked – and what we can all learn". The Conversation. Retrieved 2020-05-14.